This work disclosed the precise functional modulation of PTPLAD1 in orchestrating EMT and MFT co-occurring in metastatic CRC, advancing our knowledge of CRC pathogenesis and allowing new possibility for developing novel therapeutic strategies against CRC. This evidence concerns the gene HACD3 and colorectal carcinoma.